Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409

NCT02255656

CompletedPhase 4

Sponsor: Genzyme, a Sanofi Company

Conditions: Relapsing Remitting Multiple Sclerosis

Interventions: alemtuzumab GZ402673

Countries: United States, Argentina, Australia, Belgium, Brazil, Canada, Czechia, Denmark

Primary Objective: To evaluate long-term safety of alemtuzumab. Secondary Objectives: * To evaluate long term efficacy of alemtuzumab. * To evaluate the safety profile of participants who received other Disease Modifying Treatment (DMT) following alemtuzumab treatment. * To evaluate participant-reported Quality of Life (QoL) outcomes and health resource utilization of participant who received alemtuzumab. * To evaluate as needed re-treatment with alemtuzumab and other DMTs.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion criteria:

Participant had completed at least 48 months of the Extension Study CAMMS03409. Signed written informed consent form.

Exclusion criteria:

Participant participating in another investigational interventional study.

The above information was not intended to contain all considerations relevant to a participant's potential participation in a clinical trial.
Locations (131)
  • Cullman, Alabama, United States
  • Phoenix, Arizona, United States
  • Phoenix, Arizona, United States
  • Tucson, Arizona, United States
  • Berkeley, California, United States
  • Fullerton, California, United States
  • Pasadena, California, United States
  • Fort Collins, Colorado, United States
  • Jacksonville, Florida, United States
  • Maitland, Florida, United States
  • Sarasota, Florida, United States
  • Sunrise, Florida, United States
  • Tampa, Florida, United States
  • Tampa, Florida, United States
  • Northbrook, Illinois, United States
  • Fort Wayne, Indiana, United States
  • Indianapolis, Indiana, United States
  • Des Moines, Iowa, United States
  • Kansas City, Kansas, United States
  • Lenexa, Kansas, United States
  • Lexington, Kentucky, United States
  • Louisville, Kentucky, United States
  • Wellesley, Massachusetts, United States
  • Worcester, Massachusetts, United States
  • Ann Arbor, Michigan, United States
  • Detroit, Michigan, United States
  • Traverse City, Michigan, United States
  • Kansas City, Missouri, United States
  • St Louis, Missouri, United States
  • Teaneck, New Jersey, United States
  • + 101 more on CT.gov